SXL
TECH icon

Summit X LLC’s Bio-Techne TECH Stock Holding History

Summit X LLC’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-380
Closed -$248 – 412
2020
Q3 		$248 Buy
+380
New +$24.7K ﹤0.01% 388

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit X LLC's TECH Position: Q4 2020 in Review

Summit X LLC sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 380 shares — an estimated $248 sold.

Summit X LLC first reported a position in TECH in Q3 2020 and held it in 1 quarter. The position peaked at $248 in Q3 2020. 440 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

  • Summit X LLC reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
  • Summit X LLC sold 380 Bio-Techne shares in Q4 2020, an estimated $248.
  • Summit X LLC first reported a position in Bio-Techne in Q3 2020 and held it in 1 quarter.
  • Summit X LLC's Bio-Techne position peaked at $248 in Q3 2020.
  • 440 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Summit X LLC's 13F filing for Q4 2020, filed 29 Jan 2021.